Changes

* For variants with MAF >5%, 94.6% (Affymetrix) and 89.2% (Illumina)

* For variants with MAF >5%, 94.6% (Affymetrix) and 89.2% (Illumina)

The evaluation is based on imputation of ~600 UK samples that have been whole genome and whole exome sequenced (comparing imputed genotypes and the sequenced based calls) and using a panel of 2,500 sequenced individuals from the T2D-Go Project (Altshuler, Boehnke, McCarthy) as a reference.

The evaluation is based on imputation of ~600 UK samples that have been whole genome and whole exome sequenced (comparing imputed genotypes and the sequenced based calls) and using a panel of 2,650 sequenced individuals from the T2D-Go Project (Altshuler, Boehnke, McCarthy) as a reference.

All evaluations used [[Minimac]] and were carried out by [mailto:cfuchsb@umich.edu Christian Fuchsberger].

All evaluations used [[Minimac]] and were carried out by [mailto:cfuchsb@umich.edu Christian Fuchsberger].